BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res. 1999;90:1238-1243. [PMID: 10622535 DOI: 10.1111/j.1349-7006.1999.tb00702.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Han J, Gao X, Liu R, Yang J, Zhang M, Mi Y, Shi Y, Gao Q. Design, Synthesis of Novel Platinum(II) Glycoconjugates, and Evaluation of Their Antitumor Effects. Chem Biol Drug Des 2016;87:867-77. [DOI: 10.1111/cbdd.12718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ziegler GC, Almos P, McNeill RV, Jansch C, Lesch KP. Cellular effects and clinical implications of SLC2A3 copy number variation. J Cell Physiol 2020;235:9021-36. [PMID: 32372501 DOI: 10.1002/jcp.29753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Osumi H, Horiguchi H, Kadomatsu T, Tashiro K, Morinaga J, Takahashi T, Ikeda K, Ito T, Suzuki M, Endo M, Oike Y. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells. Cancer Sci 2020;111:1241-53. [PMID: 32012400 DOI: 10.1111/cas.14337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nguyen XC, So Y, Chung JH, Lee WW, Park SY, Kim SE. High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake. Eur J Cancer 2008;44:692-8. [PMID: 18314327 DOI: 10.1016/j.ejca.2008.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
5 Goldman NA, Katz EB, Glenn AS, Weldon RH, Jones JG, Lynch U, Fezzari MJ, Runowicz CD, Goldberg GL, Charron MJ. GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Mod Pathol. 2006;19:1429-1436. [PMID: 16892013 DOI: 10.1038/modpathol.3800656] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
6 Mamede M, Higashi T, Kitaichi M, Ishizu K, Ishimori T, Nakamoto Y, Yanagihara K, Li M, Tanaka F, Wada H. [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia. 2005;7:369-379. [PMID: 15967114 DOI: 10.1593/neo.04577] [Cited by in Crossref: 170] [Cited by in F6Publishing: 157] [Article Influence: 10.0] [Reference Citation Analysis]
7 Kalsi KK, Baker EH, Medina RA, Rice S, Wood DM, Ratoff JC, Philips BJ, Baines DL. Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch 2008;456:991-1003. [PMID: 18239936 DOI: 10.1007/s00424-008-0459-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
8 Chappell JC, Payne LB, Rathmell WK. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. J Clin Invest 2019;129:442-51. [PMID: 30614813 DOI: 10.1172/JCI120855] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
9 Ishikawa N, Oguri T, Isobe T, Fujitaka K, Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res. 2001;92:874-879. [PMID: 11509120 DOI: 10.1111/j.1349-7006.2001.tb01175.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
10 Pezzuto A, D'Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. Thorac Cancer 2020;11:3060-70. [PMID: 32945604 DOI: 10.1111/1759-7714.13651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Alves A, Mamede A, Alves M, Oliveira P, Rocha S, Botelho M, Maia C. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? CCDT 2018;19:26-40. [DOI: 10.2174/1568009618666180430144441] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
12 Lu B, Li K. Lipoic acid prevents steroid-induced osteonecrosis in rabbits. Rheumatol Int 2012;32:1679-83. [DOI: 10.1007/s00296-011-1846-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
13 Pinweha P, Rattanapornsompong K, Charoensawan V, Jitrapakdee S. MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers. Comput Struct Biotechnol J. 2016;14:223-233. [PMID: 27358718 DOI: 10.1016/j.csbj.2016.05.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
14 Lv M, Fan YB, Zhao YJ, Wang TY, Wu GP. Expression and clinical significance of glucose transporter 1 mRNA in bronchial brushing liquid-based cytology specimens from patients with and without lung cancer. Cytopathology 2012;23:108-13. [PMID: 21294792 DOI: 10.1111/j.1365-2303.2010.00846.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kanmaz ZD, Aras G, Tuncay E, Bahadır A, Kocatürk C, Yaşar ZA, Öz B, Özkurt CÜ, Gündoğan C, Çermik TF. Contribution of ¹⁸Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma. Cancer Biomark 2016;16:489-98. [PMID: 27062706 DOI: 10.3233/CBM-160588] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
16 Khandani AH, Rathmell WK. Positron emission tomography in renal cell carcinoma: an imaging biomarker in development. Semin Nucl Med 2012;42:221-30. [PMID: 22681671 DOI: 10.1053/j.semnuclmed.2012.02.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
17 Rendic S, Guengerich FP. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 2010;11:4-84. [PMID: 20302566 DOI: 10.2174/138920010791110917] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
18 Pennycooke M, Chaudary N, Shuralyova I, Zhang Y, Coe IR. Differential expression of human nucleoside transporters in normal and tumor tissue. Biochem Biophys Res Commun 2001;280:951-9. [PMID: 11162617 DOI: 10.1006/bbrc.2000.4205] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 6.1] [Reference Citation Analysis]
19 Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol. 2004;22:811-819. [PMID: 14990636 DOI: 10.1200/JCO.2004.04.109] [Cited by in Crossref: 116] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
20 Chambard JM, Ashmore JF. Sugar transport by mammalian members of the SLC26 superfamily of anion-bicarbonate exchangers. J Physiol 2003;550:667-77. [PMID: 12938672 DOI: 10.1113/jphysiol.2003.039321] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
21 Isnardi V, Clotagatide A, Bruel S, Perek N. Is [(99m)Tc]glucarate uptake mediated by fructose transporter GLUT-5? Nucl Med Biol 2012;39:1226-31. [PMID: 23084044 DOI: 10.1016/j.nucmedbio.2012.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Guaiquil VH, Vera JC, Golde DW. Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J Biol Chem. 2001;276:40955-40961. [PMID: 11533037 DOI: 10.1074/jbc.m106878200] [Cited by in Crossref: 102] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
23 Pinkerton NM, Gindy ME, Calero-DdelC VL, Wolfson T, Pagels RF, Adler D, Gao D, Li S, Wang R, Zevon M, Yao N, Pacheco C, Therien MJ, Rinaldi C, Sinko PJ, Prud'homme RK. Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging. Adv Healthc Mater 2015;4:1376-85. [PMID: 25925128 DOI: 10.1002/adhm.201400766] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
24 Hashmi S, Wang Y, Suman DS, Parhar RS, Collison K, Conca W, Al-mohanna F, Gaugler R. Human cancer: Is it linked to dysfunctional lipid metabolism? Biochimica et Biophysica Acta (BBA) - General Subjects 2015;1850:352-64. [DOI: 10.1016/j.bbagen.2014.11.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
25 Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 2009;50:1820-7. [PMID: 19837767 DOI: 10.2967/jnumed.108.054098] [Cited by in Crossref: 154] [Cited by in F6Publishing: 142] [Article Influence: 11.8] [Reference Citation Analysis]
26 Chen WL, Jin X, Wang M, Liu D, Luo Q, Tian H, Cai L, Meng L, Bi R, Wang L, Xie X, Yu G, Li L, Dong C, Cai Q, Jia W, Wei W, Jia L. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. JCI Insight 2020;5:131596. [PMID: 32051337 DOI: 10.1172/jci.insight.131596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
27 Franzius C, Kopka K, van Valen F, Eckervogt V, Riemann B, Sciuk J, Schober O. Characterization of 3-[123I]iodo-L-α-methyl tyrosine ([123I]IMT) transport into human Ewing’s sarcoma cells in vitro. Nuclear Medicine and Biology 2001;28:123-8. [DOI: 10.1016/s0969-8051(00)00186-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 O'Neill H, Malik V, Johnston C, Reynolds JV, O'Sullivan J. Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles? Pharmaceuticals (Basel) 2019;12:E16. [PMID: 30678034 DOI: 10.3390/ph12010016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Franzius C, Daldrup-link H, Sciuk J, Rummeny E, Bielack S, Jürgens H, Schober O. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT. Annals of Oncology 2001;12:479-86. [DOI: 10.1023/a:1011111322376] [Cited by in Crossref: 159] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
30 Khandani AH, Funkhouser WK, Feins R, Socinski MA. Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer. Ann Nucl Med 2009;23:595-7. [PMID: 19437096 DOI: 10.1007/s12149-009-0264-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
31 Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010;2010. [PMID: 20706540 DOI: 10.1155/2010/205357] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
32 Wu M, Li H, Liu R, Gao X, Zhang M, Liu P, Fu Z, Yang J, Zhang-Negrerie D, Gao Q. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer. Eur J Med Chem 2016;110:32-42. [PMID: 26807543 DOI: 10.1016/j.ejmech.2016.01.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
33 Gao X, Liu S, Shi Y, Huang Z, Mi Y, Mi Q, Yang J, Gao Q. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents. European Journal of Medicinal Chemistry 2017;125:372-84. [DOI: 10.1016/j.ejmech.2016.09.047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
34 Szablewski L. Expression of glucose transporters in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013;1835:164-9. [DOI: 10.1016/j.bbcan.2012.12.004] [Cited by in Crossref: 130] [Cited by in F6Publishing: 203] [Article Influence: 14.4] [Reference Citation Analysis]
35 Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch 2020;472:1273-98. [PMID: 32591906 DOI: 10.1007/s00424-020-02417-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
36 Amann T, Hellerbrand C. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009;13:1411-27. [PMID: 19874261 DOI: 10.1517/14728220903307509] [Cited by in Crossref: 118] [Cited by in F6Publishing: 119] [Article Influence: 9.8] [Reference Citation Analysis]
37 Tirpe AA, Gulei D, Ciortea SM, Crivii C, Berindan-Neagoe I. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes. Int J Mol Sci 2019;20:E6140. [PMID: 31817513 DOI: 10.3390/ijms20246140] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
38 Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A. The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep 2015;5:9149. [PMID: 25779766 DOI: 10.1038/srep09149] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
39 Qian Y, Wang X, Chen X. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World J Transl Med 2014; 3(2): 37-57 [DOI: 10.5528/wjtm.v3.i2.37] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
40 Port AM, Ruth MR, Istfan NW. Fructose consumption and cancer: is there a connection? Current Opinion in Endocrinology & Diabetes and Obesity 2012;19:367-74. [DOI: 10.1097/med.0b013e328357f0cb] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
41 Karim S, Adams DH, Lalor PF. Hepatic expression and cellular distribution of the glucose transporter family. World J Gastroenterol 2012; 18(46): 6771-6781 [PMID: 23239915 DOI: 10.3748/wjg.v18.i46.6771] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 78] [Article Influence: 8.9] [Reference Citation Analysis]
42 Huang CT, Yen RF, Cheng MF, Hsu YC, Wei PF, Tsai YJ, Tsai MF, Shih JY, Yang CH, Yang PC. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Med Oncol 2010;27:9-15. [PMID: 19130320 DOI: 10.1007/s12032-008-9160-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
43 Gao M, Huang J, Jiang X, Yuan Y, Pang H, Luo S, Wang N, Yao C, Lin Z, Pu D, Zhang S, Sun P, Liu Z, Xiao Y, Wang Q, Hu Z, Yin H. Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters. Protein Cell 2020;11:446-51. [PMID: 32410006 DOI: 10.1007/s13238-020-00725-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Madunić IV, Madunić J, Breljak D, Karaica D, Sabolić I. Sodium-glucose cotransporters: new targets of cancer therapy? Arh Hig Rada Toksikol 2018;69:278-85. [PMID: 30864374 DOI: 10.2478/aiht-2018-69-3204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
45 Chiba I, Ogawa K, Morioka T, Shimoji H, Sunagawa N, Iraha S, Nishimaki T, Yoshimi N, Murayama S. Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Oncol Lett 2011;2:21-8. [PMID: 22870123 DOI: 10.3892/ol.2010.199] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
46 Gallagher EJ, LeRoith D. Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Ann N Y Acad Sci 2011;1243:54-68. [PMID: 22211893 DOI: 10.1111/j.1749-6632.2011.06285.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 114] [Article Influence: 13.3] [Reference Citation Analysis]
47 Song X, Liu Y, Shao J, Zhang Z, Xie C, Qiao X, Bao W, Xu J. Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone. European Journal of Medicinal Chemistry 2018;157:188-97. [DOI: 10.1016/j.ejmech.2018.07.075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Valle-Mendiola A, Soto-Cruz I. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes. Cancers (Basel) 2020;12:E124. [PMID: 31947710 DOI: 10.3390/cancers12010124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
49 Chan KK, Chan JY, Chung KK, Fung KP. Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5. J Cell Biochem 2004;93:1134-42. [PMID: 15449313 DOI: 10.1002/jcb.20270] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
50 Carvalho TM, Cardoso HJ, Figueira MI, Vaz CV, Socorro S. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy. Eur J Med Chem 2019;171:343-63. [PMID: 30928707 DOI: 10.1016/j.ejmech.2019.03.053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
51 Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr 2007;137:2171-84. [PMID: 17884994 DOI: 10.1093/jn/137.10.2171] [Cited by in Crossref: 227] [Cited by in F6Publishing: 163] [Article Influence: 15.1] [Reference Citation Analysis]
52 Li T, Gao X, Yang L, Shi Y, Gao Q. Methyl 6-Amino-6-deoxy- d -pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism. ChemMedChem 2016;11:1069-77. [DOI: 10.1002/cmdc.201600079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Barron CC, Bilan PJ, Tsakiridis T, Tsiani E. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 2016;65:124-139. [PMID: 26773935 DOI: 10.1016/j.metabol.2015.10.007] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 25.6] [Reference Citation Analysis]
54 Ashrafizadeh M, Mirzaei S, Hushmandi K, Rahmanian V, Zabolian A, Raei M, Farahani MV, Goharrizi MASB, Khan H, Zarrabi A, Samarghandian S. Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects. Life Sci 2021;278:119649. [PMID: 34043989 DOI: 10.1016/j.lfs.2021.119649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Sharma R, Liaw K, Sharma A, Jimenez A, Chang M, Salazar S, Amlani I, Kannan S, Kannan RM. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. J Control Release 2021;337:179-92. [PMID: 34274384 DOI: 10.1016/j.jconrel.2021.07.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Godoy A, Ulloa V, Rodríguez F, Reinicke K, Yañez AJ, García MDLA, Medina RA, Carrasco M, Barberis S, Castro T, Martínez F, Koch X, Vera JC, Poblete MT, Figueroa CD, Peruzzo B, Pérez F, Nualart F. Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: Ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 2006;207:614-27. [DOI: 10.1002/jcp.20606] [Cited by in Crossref: 154] [Cited by in F6Publishing: 155] [Article Influence: 9.6] [Reference Citation Analysis]
57 Frolova AI, Moley KH. Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles. Reproduction 2011;142:211-20. [PMID: 21642384 DOI: 10.1530/REP-11-0114] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
58 Camp JV, Bagci U, Chu YK, Squier B, Fraig M, Uriarte SM, Guo H, Mollura DJ, Jonsson CB. Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils. J Virol 2015;89:8733-48. [PMID: 26063430 DOI: 10.1128/JVI.00817-15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
59 Ai B, Fu X, Liao Y. [The relationship of GLUT1 and lung cancer and its PET imaging]. Zhongguo Fei Ai Za Zhi 2010;13:165-7. [PMID: 20673512 DOI: 10.3779/j.issn.1009-3419.2010.02.17] [Reference Citation Analysis]
60 Györke T, Zajic T, Lange A, Schäfer O, Moser E, Makó E, Brink I. Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun 2006;27:17-24. [PMID: 16340719 DOI: 10.1097/01.mnm.0000186608.12895.69] [Cited by in Crossref: 95] [Cited by in F6Publishing: 69] [Article Influence: 5.9] [Reference Citation Analysis]